Annual Cash & Cash Equivalents
$100.79 M
+$22.37 M+28.53%
December 31, 2024
Summary
- As of March 12, 2025, GHRS annual cash & cash equivalents is $100.79 million, with the most recent change of +$22.37 million (+28.53%) on December 31, 2024.
- During the last 3 years, GHRS annual cash & cash equivalents has fallen by -$175.99 million (-63.58%).
- GHRS annual cash & cash equivalents is now -63.58% below its all-time high of $276.78 million, reached on December 31, 2021.
Performance
GHRS Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$100.79 M
+$10.73 M+11.92%
December 31, 2024
Summary
- As of March 12, 2025, GHRS quarterly cash and cash equivalents is $100.79 million, with the most recent change of +$10.73 million (+11.92%) on December 31, 2024.
- Over the past year, GHRS quarterly cash and cash equivalents has increased by +$10.73 million (+11.92%).
- GHRS quarterly cash and cash equivalents is now -65.56% below its all-time high of $292.63 million, reached on June 30, 2021.
Performance
GHRS Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
GHRS Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +28.5% | +11.9% |
| 3 y3 years | -63.6% | +11.9% |
| 5 y5 years | +10000.0% | +11.9% |
GHRS Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -63.6% | +28.5% | -63.6% | +30.1% |
| 5 y | 5-year | -63.6% | >+9999.0% | -65.6% | +2102.6% |
| alltime | all time | -63.6% | >+9999.0% | -65.6% | +2102.6% |
GH Research Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $100.79 M(+28.5%) | $100.79 M(+11.9%) |
| Sep 2024 | - | $90.06 M(+3.4%) |
| Jun 2024 | - | $87.13 M(+12.5%) |
| Mar 2024 | - | $77.48 M(-1.2%) |
| Dec 2023 | $78.42 M(-52.7%) | $78.42 M(-9.3%) |
| Sep 2023 | - | $86.44 M(-10.8%) |
| Jun 2023 | - | $96.89 M(-7.8%) |
| Mar 2023 | - | $105.08 M(-36.7%) |
| Dec 2022 | $165.96 M | $165.96 M(-35.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $256.94 M(-3.2%) |
| Jun 2022 | - | $265.38 M(-2.0%) |
| Mar 2022 | - | $270.75 M(-2.2%) |
| Dec 2021 | $276.78 M(+4595.1%) | $276.78 M(-1.4%) |
| Sep 2021 | - | $280.75 M(-4.1%) |
| Jun 2021 | - | $292.63 M(+6294.8%) |
| Mar 2021 | - | $4.58 M(-22.4%) |
| Dec 2020 | $5.89 M(+1083.7%) | $5.89 M |
| Dec 2019 | $498.00 K | - |
FAQ
- What is GH Research annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for GH Research?
- What is GH Research annual cash & cash equivalents year-on-year change?
- What is GH Research quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for GH Research?
- What is GH Research quarterly cash and cash equivalents year-on-year change?
What is GH Research annual cash & cash equivalents?
The current annual cash & cash equivalents of GHRS is $100.79 M
What is the all time high annual cash & cash equivalents for GH Research?
GH Research all-time high annual cash & cash equivalents is $276.78 M
What is GH Research annual cash & cash equivalents year-on-year change?
Over the past year, GHRS annual cash & cash equivalents has changed by +$22.37 M (+28.53%)
What is GH Research quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of GHRS is $100.79 M
What is the all time high quarterly cash and cash equivalents for GH Research?
GH Research all-time high quarterly cash and cash equivalents is $292.63 M
What is GH Research quarterly cash and cash equivalents year-on-year change?
Over the past year, GHRS quarterly cash and cash equivalents has changed by +$10.73 M (+11.92%)